Two new antivirals for HIV will be approved soon
Two new antivirals for HIV will be approved soon...Rescriptor (delavirdine) and Viracept (nelfinavir).
Rescriptor will be the second non-nucleoside reverse transcriptase inhibitor (NNRTI)...similar to Viramune (nevirapine).
The NNRTIs aren't as powerful as the protease inhibitors. But they have a niche in combo therapy...by boosting the efficacy of nucleosides such as AZT (Retrovir), 3TC (Epivir), etc.